Feng Chi Biotech (ROCO:6744) Scaled Net Operating Assets: 0.22 (As of Dec. 2025)


ROCO:6744 Feng Chi Biotech Corp ROCO:6744
82 GF Score
Price NT$15.60
GF Value NT$20.84
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Feng Chi Biotech Scaled Net Operating Assets?

Feng Chi Biotech ROCO:6744 +1.30% 82 Scaled Net Operating Assets is 0.22 as of Dec. 2025. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.84 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Feng Chi Biotech's operating assets for the quarter that ended in Dec. 2025 was NT$109.3 Mil. Feng Chi Biotech's operating liabilities for the quarter that ended in Dec. 2025 was NT$42.6 Mil. Feng Chi Biotech's Total Assets for the quarter that ended in Jun. 2025 was NT$305.3 Mil. Therefore, Feng Chi Biotech's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.22.

Feng Chi Biotech Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Feng Chi Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Feng Chi Biotech Scaled Net Operating Assets Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.05 0.11 0.13 0.22

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.07 0.14 0.16 0.22

ROCO:6744 vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Feng Chi Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Feng Chi Biotech Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's Scaled Net Operating Assets falls into.


ROCO:6744
82GF Score
Feng Chi Biotech Corp ROCO:6744
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Feng Chi Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Feng Chi Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(109.279-42.579)/299.071
=0.22

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=287.911 - 178.632
=109.279

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=48.007 - 2.631 - 2.797
=42.579

Feng Chi Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Jun. 2025 )
=(109.279-42.579)/305.307
=0.22

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=287.911 - 178.632
=109.279

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=48.007 - 2.631 - 2.797
=42.579

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.22 mean?
Feng Chi Biotech (ROCO:6744) has a Scaled Net Operating Assets of 0.22 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Feng Chi Biotech and its competitors.
Is Feng Chi Biotech's Scaled Net Operating Assets too high?
Feng Chi Biotech's current Scaled Net Operating Assets is 0.22. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Scaled Net Operating Assets compare to VRTX and REGN?
Feng Chi Biotech's Scaled Net Operating Assets of 0.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Feng Chi Biotech and its competitors. Feng Chi Biotech's current Scaled Net Operating Assets is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.84, compared to a current price of NT$15.60 — trading 25.1% below its estimated fair value. The current Scaled Net Operating Assets is 0.22. Feng Chi Biotech's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Scaled Net Operating Assets is 0.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?

Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued. The current stock price of NT$15.60 is trading 25.1% below its estimated GF Value™ of NT$20.84. GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.

Key valuation signals for ROCO:6744:

  • Scaled Net Operating Assets: 0.22
  • GF Value™: NT$20.84 vs. price of NT$15.60 (25.1% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Feng Chi Biotech Business Description

Address No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score

Get the complete analysis for ROCO:6744

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.60
Price
NT$20.84
GF Value